The Michael J. Fox Foundation Parkinson's Podcast

The SURE-PD study published in JAMA Neurology reports that with medical supervision, it is possible to safely raise levels of the antioxidant urate by taking the urate precursor inosine.Mentioned in this episode:April is Parkinson’s Awareness Month, and it comes with a chance for you to make a real difference. For people living with Parkinson’s and their loved ones, progress can’t wait — every new discovery, every step forward in research and every bit of your support matters. Visit our website to learn how you can get involved. http://bit.ly/48bPdM3

The Michael J. Fox Foundation Contributing Editor Dave Iverson speaks with Kalpana Merchant, PhD of Eli Lilly and Company about the latest in Parkinson's disease research.Mentioned in this episode:April is Parkinson’s Awareness Month, and it comes with a chance for you to make a real difference. For people living with Parkinson’s and their loved ones, progress can’t wait — every new discovery, every step forward in research and every bit of your support matters. Visit our website to learn how you can get involved. http://bit.ly/48bPdM3

Researchers are improving on the existing DBS technology—an implanted electrode delivers electrical pulses to stimulate or block brain signals—and how we use it.Mentioned in this episode:April is Parkinson’s Awareness Month, and it comes with a chance for you to make a real difference. For people living with Parkinson’s and their loved ones, progress can’t wait — every new discovery, every step forward in research and every bit of your support matters. Visit our website to learn how you can get involved. http://bit.ly/48bPdM3

Levels of alpha-synuclein in the brain—measured through imaging tools—could be a biomarker that would help researchers diagnose the disease better and test potential therapies faster.Mentioned in this episode:April is Parkinson’s Awareness Month, and it comes with a chance for you to make a real difference. For people living with Parkinson’s and their loved ones, progress can’t wait — every new discovery, every step forward in research and every bit of your support matters. Visit our website to learn how you can get involved. http://bit.ly/48bPdM3

Contributing Editor Dave Iverson reports on the new technology that partnership will employ and the current state of stem cell research in Parkinson’s disease. He speaks Mentioned in this episode:April is Parkinson’s Awareness Month, and it comes with a chance for you to make a real difference. For people living with Parkinson’s and their loved ones, progress can’t wait — every new discovery, every step forward in research and every bit of your support matters. Visit our website to learn how you can get involved. http://bit.ly/48bPdM3

While much research into Parkinson’s disease (PD) focuses on improving dopamine supply, there is an emerging scientific understanding that Parkinson’s goes well beyond the dopamine system. Mentioned in this episode:April is Parkinson’s Awareness Month, and it comes with a chance for you to make a real difference. For people living with Parkinson’s and their loved ones, progress can’t wait — every new discovery, every step forward in research and every bit of your support matters. Visit our website to learn how you can get involved. http://bit.ly/48bPdM3

The evolution of our understanding of genetics’ role in Parkinson’s disease (PD) and how that understanding will translate into drug discovery is the topic of a new podcast and upcoming Webinar.Mentioned in this episode:April is Parkinson’s Awareness Month, and it comes with a chance for you to make a real difference. For people living with Parkinson’s and their loved ones, progress can’t wait — every new discovery, every step forward in research and every bit of your support matters. Visit our website to learn how you can get involved. http://bit.ly/48bPdM3

Fox Trial Finder volunteer Gwen Schroeder recounts her first clinical trial experience to MJFF contributing editor Dave Iverson.Mentioned in this episode:April is Parkinson’s Awareness Month, and it comes with a chance for you to make a real difference. For people living with Parkinson’s and their loved ones, progress can’t wait — every new discovery, every step forward in research and every bit of your support matters. Visit our website to learn how you can get involved. http://bit.ly/48bPdM3

Dave Iverson speaks with the CEO of Civitas, Glenn Batchelder, and MJFF staffer Maurizio Facheris, MD, MSc to learn more about how the drug works, as well as next steps.Mentioned in this episode:April is Parkinson’s Awareness Month, and it comes with a chance for you to make a real difference. For people living with Parkinson’s and their loved ones, progress can’t wait — every new discovery, every step forward in research and every bit of your support matters. Visit our website to learn how you can get involved. http://bit.ly/48bPdM3

Dave Iverson speaks with Foundation staffer Mark Frasier to learn more about some of the early findings from the study.Mentioned in this episode:April is Parkinson’s Awareness Month, and it comes with a chance for you to make a real difference. For people living with Parkinson’s and their loved ones, progress can’t wait — every new discovery, every step forward in research and every bit of your support matters. Visit our website to learn how you can get involved. http://bit.ly/48bPdM3

Dave Iverson reports on recent disappointing clinical trial results of Ceregene’s trophic factor therapy CERE-120.Mentioned in this episode:April is Parkinson’s Awareness Month, and it comes with a chance for you to make a real difference. For people living with Parkinson’s and their loved ones, progress can’t wait — every new discovery, every step forward in research and every bit of your support matters. Visit our website to learn how you can get involved. http://bit.ly/48bPdM3

Studies have long suggested that smokers may be less likely to get Parkinson's. Here, Dave Iverson speaks with a researcher investigating the potential of nicotine patches as a PD treatment.Mentioned in this episode:April is Parkinson’s Awareness Month, and it comes with a chance for you to make a real difference. For people living with Parkinson’s and their loved ones, progress can’t wait — every new discovery, every step forward in research and every bit of your support matters. Visit our website to learn how you can get involved. http://bit.ly/48bPdM3

2013 could be a pivotal year in PD research, with expected developments on a variety of fronts. In this podcast, Dave Iverson speaks with Foundation staffers about some of that lies ahead. Mentioned in this episode:April is Parkinson’s Awareness Month, and it comes with a chance for you to make a real difference. For people living with Parkinson’s and their loved ones, progress can’t wait — every new discovery, every step forward in research and every bit of your support matters. Visit our website to learn how you can get involved. http://bit.ly/48bPdM3

Emerging evidence over the past 15 years has led researchers to believe that genetics plays a far greater role in Parkinson’s disease (PD) than was once thought. Mentioned in this episode:April is Parkinson’s Awareness Month, and it comes with a chance for you to make a real difference. For people living with Parkinson’s and their loved ones, progress can’t wait — every new discovery, every step forward in research and every bit of your support matters. Visit our website to learn how you can get involved. http://bit.ly/48bPdM3

Patients have always been at the heart of what we do at The Michael J. Fox Foundation. Our dedication to improving patients’ quality of life has shaped our research priorities.Mentioned in this episode:April is Parkinson’s Awareness Month, and it comes with a chance for you to make a real difference. For people living with Parkinson’s and their loved ones, progress can’t wait — every new discovery, every step forward in research and every bit of your support matters. Visit our website to learn how you can get involved. http://bit.ly/48bPdM3

While levodopa is the gold standard therapy for Parkinson's disease (PD), current delivery methods have their limitations.Mentioned in this episode:April is Parkinson’s Awareness Month, and it comes with a chance for you to make a real difference. For people living with Parkinson’s and their loved ones, progress can’t wait — every new discovery, every step forward in research and every bit of your support matters. Visit our website to learn how you can get involved. http://bit.ly/48bPdM3

Understanding the genetics of Parkinson’s disease could be a game changer in developing new treatments for the disease. Especially when it comes to two genetic targets: LRRK2 and alpha-synuclein. Mentioned in this episode:April is Parkinson’s Awareness Month, and it comes with a chance for you to make a real difference. For people living with Parkinson’s and their loved ones, progress can’t wait — every new discovery, every step forward in research and every bit of your support matters. Visit our website to learn how you can get involved. http://bit.ly/48bPdM3

This fall, The FDA recommended that Teva Neuroscience’s drug rasagiline, brand name Azilect, should not be granted status “to slow the clinical progression of PD.”Mentioned in this episode:April is Parkinson’s Awareness Month, and it comes with a chance for you to make a real difference. For people living with Parkinson’s and their loved ones, progress can’t wait — every new discovery, every step forward in research and every bit of your support matters. Visit our website to learn how you can get involved. http://bit.ly/48bPdM3

This past October, Austrian biotech AFFiRiS announced $1.5 million in funding from MJFF for an early stage clinical trial of a first-of-its-kind vaccine approach to treating Parkinson's disease (PD).Mentioned in this episode:April is Parkinson’s Awareness Month, and it comes with a chance for you to make a real difference. For people living with Parkinson’s and their loved ones, progress can’t wait — every new discovery, every step forward in research and every bit of your support matters. Visit our website to learn how you can get involved. http://bit.ly/48bPdM3